<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0309245855
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CLOMID 50MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CLOMIFENE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        22.5
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PATHEON FRANCE" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PATHEON FRANCE
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2218]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Sanofi Arabia Trading Co. Ltd
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            sanofi-aventis FRANCE
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        G03GB02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Clomid contains a medicine called clomifene citrate. This belongs to a group of medicines called ovulation stimulants. It works by stimulating the release of eggs from the ovary (ovulation). Clomid is used for some types of infertility, in women who are not ovulating properly. This medicine is used:<br />&bull;to treat certain types of infertility,<br />&bull;to carry out a test that makes it possible to diagnose and treat certain types of amenorrhea(lack of menstrual periods),<br />&bull;to trigger ovulation in the context of medically-assisted procreation.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>If your doctor has told you that you have an intolerance to certain sugars, contact him/her before taking this medicine.<br /><strong>Contraindications<br />Do not take Clomid:</strong><br />&bull;if you are allergic to clomifene citrate or any of the other ingredients of this medicine (listedin section 6).<br />&bull;if you have or recently had a serious liver disease,<br />&bull;if you have unexplained vaginal bleeding,<br />&bull;if you have breast or genital cancer (hormone-dependent tumors),<br />&bull;if you have an organic ovarian cyst,<br />&bull;if you have ongoing visual disturbances or if you had them during previous treatment with Clomid.<br /><strong>Appropriate precautions for use, special warning</strong></p><p><br /><strong>Warnings and precautions</strong><br />Talk to your doctor before taking Clomid.<br />&bull; This medicine should only be used under specialized medical monitoring and strict monitoring of laboratory test results (particularly hormone assays).<br />&bull; Couples should be warned that use of Clomid causes a risk of a multiple pregnancy.<br />&bull; If you are overweight, your doctor will advise you to go on a diet.<br /><strong>Before you take Clomid:</strong><br />Tell your doctor if you or someone in your family has ever had hypertriglyceridemia (high levels of fats in the blood). If this is the case, your doctor may suggest that you have blood tests periodically to monitor your fat levels for the duration of treatment.<br /><strong>During treatment:</strong><br />&bull; Do not change the dosage, duration or days of treatment established by your specialist for any reason whatsoever.<br />&bull; Do not forget to have the requested laboratory tests done on the days scheduled by your specialist (particularly blood tests).<br />&bull; If you are receiving long-term treatment, your doctor may check your levels of cholesterol (another type of fat) in the blood.<br />&bull; Tell your doctor:<br />&bull; if you have pain in your lower abdomen,<br />&bull; if you gain weight,<br />&bull; if you have an overall bloated feeling,<br />&bull; if visual disturbances develop. Treatment will be stopped permanently and a thorough eye examination will be performed.<br />&bull; if you have vaginal dryness. You will be prescribed an appropriate additional treatment.<br /><strong>Other medicines and Clomid</strong><br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.<br /><strong>Pregnancy</strong><br />Clomid must be stopped as soon as you discover that you are pregnant (risk of malformation observed in animal studies and suspected in women). If you discover that you are pregnant during treatment, consult your doctor.<br /><strong>Breast-feeding</strong><br />Given that there is no information about whether clomifene passes into breast milk, you must not take Clomid if you are breast-feeding. It is not known whether clomifene passes into breast milk.<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<br /><strong>Driving and using machines</strong><br />Your ability to drive vehicles and use machines may be impaired by some of the side effects of this treatment, such as visual disturbances, particularly when there are changes in light levels.</p><p><strong>Clomid contains sucrose and lactose monohydrate</strong><br />This medicine contains lactose. Use of this medicine is not recommended if you have galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption syndrome (rare hereditary diseases).<br />This medicine contains sucrose. Use of this medicine is not recommended if you have fructose intolerance, glucose-galactose malabsorption syndrome or sucrase/isomaltase deficiency (rare hereditary diseases).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Dosage</strong><br />The dose to be taken will be determined by your doctor.<br />Always comply with the dose that he or she has prescribed for you. The usual dose is 1 to 2 tablets daily for 5 days per treatment course. If you are unsure of anything, consult your doctor or pharmacist.<br /><strong>Method and route of administration</strong><br />Swallow the tablets with half a glass of water (oral use).<br /><strong>Duration of treatment</strong><br />You should not take more than 6 courses of Clomid treatment.<br />Do not change or suddenly stop treatment without your doctor&rsquo;s permission.<br /><strong>If you take more Clomid than you should:</strong><br />Contact your doctor or pharmacist immediately.<br />Tell your doctor immediately if you experience:<br />&bull; Nausea, vomiting.<br />&bull; Hot flushes.<br />&bull; Pain in the pelvis (lower abdomen).<br />&bull; Weight gain.<br />&bull; Overall bloated feeling.<br />&bull; Blurred vision or other visual disturbances; you must stop treatment immediately and tell your doctor. You will need to have a thorough eye test.<br /><strong>If you forget to take Clomid:</strong><br />Do not take a double dose to make up for a forgotten dose.<br />Take the next dose at the usual time.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />&bull; Hot flushes, nausea, vomiting, abdominal and pelvic (lower abdomen) discomfort, fatigue, dizzy spells, lightheadedness, giddiness, tingling, headache, nervousness, depression, anxiety, and mood disorders,<br />&bull; insomnia, heavy menstrual periods, bleeding between periods, sensitive breasts, skin reactions, hair loss, frequent urination,<br />&bull; increased ovarian size and function, leading to pain in the lower abdomen during treatment,<br />&bull; rparegnancy including pregnancies inside and outside the womb at the same time,<strong> </strong></p><p>&bull; insufficient cervical mucus (normal secretion produced by the cervix),<br />&bull; visual disturbances that often disappear when treatment is stopped. However, cases of visual disturbances that persisted even after stopping treatment have been reported. These can be irreversible, particularly if you exceed the recommended dosage and/or treatment duration. If these symptoms occur during a course of Clomid, treatment must be stopped permanently and a thorough eye examination must be performed,<br />&bull; palpitations, tachycardia (acceleration of heart rate),<br />&bull; increased liver enzyme levels,<br />&bull; inflammation of the pancreas,<br />&bull; cases of increased levels of fat in the blood (hypertriglyceridemia),<br />&bull; possible occurrence of endometriosis (presence of some of the internal lining of the womb growing outside of the womb, which can cause pain and bleeding) or worsening of pre-existing endometriosis,<br />&bull; reduced thickness of the endometrium.<br />&bull; cases of seizures have been reported,<br />&bull; isolated cases of development or worsening of certain tumors, most often hormone-dependent tumors, have been reported,<br />&bull; some cases of worsening of pre-existing psychosis (mental disorder) have been reported.<br /><strong>Reporting of side effects<br />To report any side effect(s):<br />&bull; Saudi Arabia:</strong><br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />&bull; SFDA call center : 19999<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: https://ade.sfda.gov.sa/<br />&bull; Sanofi- Pharmacovigilance: KSA_Pharmacovigilance@sanofi.com</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is indicated on the box. The expiry date refers to the last day of that month.<br />Store below 25&deg;C, protected from light and moisture.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Clomid 50 mg tablets contain<br />&bull; The active substance is:<br />Clomifene citrate .................................................................................................. 50 mg<br />For 1 tablet<br />&bull; The other ingredients are: sucrose, lactose monohydrate, maize starch, soluble starch, magnesium stearate, yellow iron oxide (E172)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Clomid 50 mg tablets look like and contents of the pack
This medicine is available as tablets. One box may contain 5 or 10 tablets.
Not all pack size may be marketed in your country
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder</strong><br />sanofi-aventis France<br />82, avenue Raspail<br />94250 Gentilly<br />France</p><p><strong>Manufacturer</strong><br />Patheon France<br />40, boulevard de Champaret<br />38300 Bourgoin Jallieu<br />France<br />Zentiva, k.s<br />U kabelovny 130, 102 37, Prague, 10,<br />Czech Republic</p><p><strong>Secondary packager</strong><br />Sanofi Aventis Arabia Co. Ltd<br />Industrial Valley Phase 1A St.,<br />King Abdullah Economic City, Rabigh, 21423,<br />Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                December 2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>كلومید یحتوي على المادة الفعالة كلومیفین سترات. والتي تنتمي لمجموعة الأدویة المحفزة للإباضة .<br />یعمل كلومید على تحفیز عملیة إطلاق البویضات من المبیض.(الاباضة)<br />كلومید یستخدم لحل بعض المشاكل المتعلقة بالخصوبة عند النساء الذین یعانون من نقص الاباضة الطبیعة .<br />يُستعمل هذا الدواء :<br />&bull; لعلاج بعض أنواع العقم،<br />&bull; لإجراء فحص يجعل من الممكن تشخيص بعض أنواع إنحباس الطمث )غياب الدورة الشهريّة(،<br />&bull; لتنشيط الإباضة في سياق الإنجاب بمساعدة طبيّة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>إذا قال لكِ طبيبك إنّك تعانين من عدم تحمّل بعض أنواع السكّر، اتصلي به قبل أخذ هذا الدواء.<br /><strong><u>موانع الاستعمال</u><br />لا تأخذي كلوميد:</strong><br />&bull; إذا كنتِ تعانين من حساسيّة ضدّ المادة الفاعلة سترات الكلوميفن أو ضدّ أيّ مركّب من مركّبات هذا الدواء الأخرى<br />)المذكورة في القسم 6 (،<br />&bull; إذا كنتِ تعانين من مرض كبديّ حاد أو حديث،<br />&bull; إذا كنتِ تعانين من نزف مهبليّ سببه غير معروف،<br />&bull; إذا كنتِ تعانين من سرطان الثدي أو سرطان الأعضاء التناسليّة )أورام معتمدة على الهرمونات(،<br />&bull; إذا كنتِ تعانين من كيسات المبيض العضويّة ،<br />&bull; إذا كنتِ تعانين من اضطرابات بصريّة خلال العلاج الحالي أو حصلت هذه الاضطرابات خلال علاج سابق بكلوميد.<br /><strong><u>احتياطات الاستعمال، تحذيرات خاصة</u><br />تحذيرات واحتياطات</strong><br />استشيري طبيبك قبل أخذ كلوميد.<br />&bull; لا ينبغي استعمال هذا الدواء إلاّ تحت مراقبة طبيّة متخصصة ومراقبة صارمة لنتائج التحاليل المخبريّة )خصوصًا<br />الفحوصات الهرمونيّة(.<br />&bull; يجب إعلام الزوجين بأنّ أخذ كلوميد يمكن أن يسبّب خطر الحمل المتعدّد.<br />&bull; إذا كنت تعانين من زيادة في الوزن، سوف ينصحك طبيبك باتباع حمية.</p><p><strong>قبل أن تأخذي كلوميد:</strong><br />أعلمي طبيبك إذا كنت تعانين حاليًا أو عانيتِ أنت أو فرد من عائلتك من فرط ثلاثي غليسيريد الدم )مستويات مرتفعة من<br />الشحوم في الدم(. في هذه الحالة ، قد يقترح طبيبك عليك إجراء فحوصات دم منتظمة لمراقبة مستويات الشحوم لديك خلال مدّة<br />العلاج كلّها.<br /><strong>خلال العلاج:</strong><br />&bull; لا ينبغي عليك مطلقًا تغيير مقدار الجرعة أو مدّة العلاج أو أيّام العلاج التي حدّدها الطبيب الأخصّائي لأيّ سبب من<br />الأسباب.<br />&bull; لا تنسي إجراء الفحوصات المخبريّة المطلوبة في الأيّام التي حدّدها الطبيب الأخصّائي )بخاصة فحوصات الدم(.<br />&bull; إذا كنت تتلقّين الدواء لوقت طويل، قد يتحقق طبيبك من مستويات الكولستيرول )نوع آخر من الشحوم( في دمك.<br />&bull; أعلمي طبيبك:<br />&bull; إذا كنت تعانين من ألم في أسفل البطن،<br />&bull; إذا زاد وزنك،<br />&bull; إذا كان لديك شعور عام بالنفخة ،<br />&bull; إذا أصبتِ باضطرابات بصريّة. يجب إيقاف العلاج وإجراء فحص دقيق للعينين.<br />&bull; إذا كنت تعانين من جفاف في المهبل، سوف يصف لكِ طبيبكِ علاجًا إضافيًا مناسبًا.<br /><strong>أدوية أخرى وكلوميد</strong><br />أعلمي طبيبكِ أو الصيدليّ إذا كنتِ تأخذين حاليًا أو أخذتِ مؤخّرًا أو قد تأخذين أيّ دواء آخر.<br /><strong>الحمل</strong><br />يجب إيقاف كلوميد حالما تكتشفين حملك )بسبب خطر التشوّه المثبت في التجارب لدى الحيوانات والمشتبه بحدوثه لدى المرأة(.<br />إذا اكتشفت حملك خلال مدّة العلاج، استشيري طبيبك.<br /><strong>الإرضاع</strong><br />في ظلّ عدم توافر معلومات حول إمكانيّة انتقال الكلوميفن إلى حليب الثدي، لا ينبغي عليك أخذ كلوميد إذا كنتِ تُرضعين. من<br />غير المعروف ما إذا كان الكلوميفن يُفرز في حليب الثدي.<br />إذا كنتِ حاملاً أو مرضعة، أو إذا كنت تعتقدين نفسك حاملاً أو إذا كنت تنوين الحمل، استشيري الطبيب أو الصيدليّ قبل أخذ هذا<br />الدواء.<br /><strong>قيادة السيّارات واستعمال الآلات</strong><br />قد تضعف قدرتك على قيادة السيّارات واستعمال الآلات بسبب بعض التأثيرات الجانبيّة الناتجة عن هذا العلاج مثل الاضطرابات<br />البصريّة بخاصة في ظلّ وجود تقلّبات في مستويات الضوء.<br /><strong>يحتوي كلوميد على السكروز وعلى اللاكتوز الوحيد التميّه</strong><br />يحتوي هذا الدواء على اللاكتوز. لا يوصى باستعمال هذا الدواء لدى المرضى الذين يعانون من عدم تحمّل الغالاكتوز أو من<br />نقص لاكتاز-لاب أو من متلازمة سوء امتصاص الغلوكوز أو الغالاكتوز )أمراض وراثيّة نادرة(.<br />يحتوي هذا الدواء على السكروز. لا يُنصح باستعمال هذا الدواء لدى المرضى الذين يعانون من عدم تحمّل الفروكتوز أو من<br />متلازمة سوء امتصاص الغلوكوز والغالاكتوز أو من نقص السكراز/إيزومالتاز )أمراض وراثيّة نادرة(.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>مقدار الجرعة</strong><br />سوف يحدّد طبيبك الجرعة الواجب أخذها.<br />خذي دائمًا الجرعة التي يصفها طبيبك. تتراوح الجرعة العاديّة بين قرص وقرصين يوميًا لخمسة أيّام في الدورة العلاجيّة الواحدة.<br />إذا كان لديك أيّ شكّ، استشيري الطبيب أو الصيدلي.<br /><strong>طريقة الاستعمال</strong><br />إبلعي الأقراص مع نصف كوب من الماء )عن طريق الفم(.</p><p><strong>مدّة العلاج</strong><br />لا ينبغي أن يتجاوز علاجك بكلوميد 6 دورات علاجيّة.<br />لا تغيّري أو توقفي العلاج فجأة بدون موافقة طبيبك.<br /><strong>إذا أخذتِ كميّة مفرطة من كلوميد:</strong><br />استشيري طبيبك أو الصيدلي على الفور.<br />أعلمي طبيبك على الفور إذا عانيتِ من:<br />&bull; غثيان، تقيّؤ.<br />&bull; هبّات ساخنة.<br />&bull; ألم في الحوض )أسفل البطن( .<br />&bull; زيادة في الوزن.<br />&bull; شعور عام بالانتفاخ.<br />&bull; عدم وضوح الرؤية أو اضطرابات بصريّة أخرى؛ يجب عليكِ إيقاف العلاج على الفور وإعلام الطبيب. ستحتاجين أيضًا<br />لإجراء فحص كامل للنظر.<br /><strong>إذا نسيت أخذ كلوميد:</strong><br />لا تأخذي جرعة مضاعفة للتعويض عن الجرعة التي نسيت أخذها وخذي الجرعة التالية في وقتها الاعتيادي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن أن يسبّب هذا الدواء تأثيرات جانبيّة لا تصيب المرضى كلّهم.<br />&bull; هبّات ساخنة، غثيان، تقيّؤ، انزعاج في البطن والحوض )أسفل البطن(، تعب، دوار، دوخة، شعور بالثمل، صداع، توتّر،<br />اكتئاب، قلق، اضطرابات في المزاج،<br />&bull; أرق، دورات شهريّة غزيرة، نزف بين الدورات الشهريّة، ثديان حسّاسان، ارتكاسات جلديّة، تساقط الشعر، كثرة التبوّل،<br />&bull; زيادة حجم المبيض ووظيفته، مما يسبّب ألمًا في أسفل البطن خلال العلاج،<br />&bull; خطر حصول حمل متعدّد بما في ذلك حالات حمل داخل الرّحم وخارجه في الوقت ذاته ،<br />&bull; كميّة غير كافية من مخاط عنق الرّحم )إفراز طبيعي من عنق الرّحم(،<br />&bull; اضطرابات بصريّة غالبًا ما تختفي عند إيقاف العلاج. ولكن أفيد عن استمرار حالات من الاضطرابات البصريّة حتّى بعد<br />إيقاف العلاج. يمكن ألاّ تزول هذه الاضطرابات البصر يّة، لا سيّما إذا تجاوز مقدار الجرعة الموصى به و/أو مدّة العلاج<br />الجرعة أو المدّة الموصى بهما. في حال حصلت هذه الأعرا ض خلال دورة علاجيّة بكلوميد، يجب عليكِ إيقاف العلاج بشكل<br />دائم والخضوع لفحص بصر كامل،<br />&bull; خفقان، وعدم انتظام دقات القلب )تسارع معدل ضربات القلب(،<br />&bull; إرتفاع الانزيمات الكبديّة،<br />&bull; التهاب البنكرياس،<br />&bull; حالات ارتفاع مستويات الشحوم في الدم )فرط ثلاثي غليسيريد الدم(،<br />&bull; خطر الإصابة ببُطان رحمي )أجزاء من البطانة الداخليّة للرّحم تنمو خارج الرّحم مما قد يسبّب ألمًا ونزفًا( أو تفاقم البُطان<br />الرحمي الموجود أصلاً،<br />&bull; انخفاض سماكة بطانة الرحم،<br />&bull; أفيد عن حالات من الاختلاجات،<br />&bull; أفيد عن حالات معزولة من نموّ أو تفاقم بعض الأورام وكانت غالبًا أورامًا تتعلّق بالهرمونات،<br />&bull; أفيد عن تفاقم بعض حالات الذُهان )اضطراب عقلي( الموجود أصلاً.<br /><strong>للإبلاغ عن أي أعراض جانبية :<br />&bull; المملكة العربية السعودية :</strong><br />- المركز الوطني للتيقظ والسلامة الدوائية<br />&bull; الرقم المُوحّد للهيئة العامّة للغذاء والدّواء: 19999<br />&bull; البريد الالكتروني: npc.drug@sfda.gov.sa<br />&bull; الموقع الالكتروني: e.sfda.gov.sahttps://ad<br />&bull; سانوفي للتيقظ الدوائي: KSA_Pharmacovigilance@sanofi.com</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يُحفظ هذا الدواء بعيدًا عن نظر الأطفال ومتناولهم.<br />لا ينبغي استعمال هذا الدواء بعد انقضاء تاريخ انتهاء الصلاحيّة المدوّن على العلبة. يشير هذا التاريخ إلى اليوم الأخير من الشهر<br />المذكور.<br />يُحفظ في درجة حرارة ما دون 25 درجة مئويّة، بعيدًا عن النور والرطوبة.<br />لا ينبغي رمي الأدوية في مياه الصرف الصحي أو مع النفايات المنزليّة. أطلبي من الصيدلي التخلّص من الأدوية التي لم تعودي<br />تستعملينها، فمن شأن هذه الإجراءات حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ماذا يحتوي كلوميد 50 ملغ، أقراص<br />&bull; المادة الفاعلة هي :<br />سترات الكلوميفين..................................................................................................................... 50 ملغ<br />في القرص الواح د<br />&bull; المركّبات الأخرى هي: سكروز، لاكتوز وحيد التميّه، نشا الذرة، نشا قابل للذوبان، ستيارات المغنيزيوم، أكسيد الحديد<br />الأصفر )إي 172 )</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">كيف هو شكل كلوميد 50 ملغ، أقراص ومحتويات العلبة الخارجيّة<br />يأتي هذا الدواء على شكل أقر اص. قد تحتوي العلبة على 5 أو 10 أقراص.<br />قد لا تكون أحجام العلب كلّها مسوّقة في بلدك.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>حامل رخصة التسويق</strong><br />sanofi-aventis France<br />82, avenue Raspail<br />94250 Gentilly<br />France</p><p><strong>المصنّع</strong><br />Patheon France<br />40, boulevard de Champaret<br />38300 Bourgoin Jallieu<br />France<br />Zentiva, k.s<br />U kabelovny 130, 102 37, Prague, 10,<br />Czech Republic</p><p><strong>التغليف الثانوي</strong><br />,Sanofi Aventis Arabia Co. Ltd<br />Industrial Valley Phase 1A St.,<br />King Abdullah Economic City, Rabigh, 21423,<br />Saudi Arabia</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            ديسمبر /2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Clomid™ 50 mg Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Clomifene Citrate 50 mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clomid 50 mg Tablets (Clomifene Citrate BP) is indicated for the treatment of ovulatory failure in women desiring pregnancy. Clomid 50 mg Tablets is indicated only for patients in whom ovulatory dysfunction is demonstrated. Other causes of infertility must be excluded or adequately treated before giving Clomid 50 mg Tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u><br /><u>Adults</u><br />The recommended dose for the first course of Clomid 50 mg Tablets (Clomifene Citrate BP) is 50 mg (1 tablet) daily for 5 days. Therapy may be started at any time in the patient who has had no recent uterine bleeding. If progestin-induced bleeding is planned, or if spontaneous uterine bleeding occurs before therapy, the regimen of 50 mg daily for 5 days should be started on or about the fifth day of the cycle. When ovulation occurs at this dosage, there is no advantage to increasing the dose in subsequent cycles of treatment.<br />If ovulation appears not to have occurred after the first course of therapy, a second course of 100 mg daily (two 50 mg tablets given as a single daily dose) for 5 days should be given. This course may be started as early as 30 days after the previous one. Increase of the dosage or duration of therapy beyond 100 mg/day for 5 days should not be undertaken.<br />The majority of patients who are going to respond will respond to the first course of therapy, and 3 courses should constitute an adequate therapeutic trial. If ovulatory menses have not yet occurred, the diagnosis should be re-evaluated. Treatment beyond this is not recommended in the patient who does not exhibit evidence of ovulation.<br />Long-term cyclic therapy.</p><p>Not recommended.<br />Efficacy and safety of clomifene for more than 6 treatment cycles have not been demonstrated.<br /><u>Special Populations</u><br />Special care with lower dosage or duration of treatment is particularly recommended if unusual sensitivity to pituitary gonadotrophin is suspected, such as in patients with polycystic ovary syndrome (see section 5.1).<br /><u>Method of Administration</u><br />Oral.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pregnancy: See section 4.6.
Liver disease: Clomid 50 mg Tablets (Clomifene Citrate BP) therapy is contraindicated in patients with liver disease or a history of liver dysfunction.
Hormone-Dependent Tumours or Abnormal uterine bleeding: Clomid 50 mg Tablets is contraindicated in patients with hormone-dependent tumours or in patients with abnormal uterine bleeding of undetermined origin.
Ovarian cyst: Clomid 50 mg Tablets should not be given in the presence of an ovarian cyst, except polycystic ovary, since further enlargement of the cyst may occur. Patients should be evaluated for the presence of ovarian cyst prior to each course of treatment.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Warnings:<br />General</u>:<br />Good levels of endogenous oestrogen (as estimated from vaginal smears, endometrial biopsy, assay of urinary oestrogen, or endometrial bleeding in response to progesterone) provide a favourable prognosis for ovulatory response induced by Clomid 50 mg Tablets. A low level of oestrogen, although clinically less favourable, does not preclude successful outcome of therapy. Clomid 50 mg Tablets therapy is ineffective in patients with primary pituitary or primary ovarian failure. Clomid 50 mg Tablets therapy cannot be expected to substitute for specific treatment of other causes of ovulatory failure, such as thyroid or adrenal disorders. For hyperprolactinaemia there is other preferred specific treatment. Clomid 50 mg Tablets is not first line treatment for low weight related amenorrhoea, with infertility, and has no value if a high FSH blood level is observed following an early menopause.<br /><u>Ovarian Hyperstimulation Syndrome:</u><br />Ovarian Hyperstimulation Syndrome (OHSS) has been reported in patients receiving Clomid 50 mg Tablets therapy for ovulation induction. In some cases, OHSS occurred following the cyclic use of Clomid 50 mg Tablets therapy or when Clomid 50 mg Tablets was used in combination with gonadotropins. The following symptoms have been reported in association with this syndrome during Clomid 50 mg Tablets therapy: pericardial effusion, anasarca, hydrothorax, acute abdomen, renal failure, pulmonary oedema, ovarian haemorrhage, deep venous thrombosis, torsion of the ovary and acute respiratory distress. If conception results, rapid progression to the severe form of the syndrome may occur.</p><p>To minimise the hazard of the abnormal ovarian enlargement associated with Clomid 50 mg Tablets therapy, the lowest dose consistent with expectation of good results should be used. The patient should be instructed to inform the physician of any abdominal or pelvic pain, weight gain, discomfort or distension after taking Clomid 50 mg Tablets. Maximal enlargement of the ovary may not occur until several days after discontinuation of the course of Clomid 50 mg Tablets. Some patients with polycystic ovary syndrome who are unusually sensitive to gonadotropin may have an exaggerated response to usual doses of Clomid 50 mg Tablets.<br />The patient who complains of abdominal or pelvic pain, discomfort, or distension after taking Clomid 50 mg Tablets should be examined because of the possible presence of an ovarian cyst or other cause. Due to fragility of enlarged ovaries in severe cases, abdominal and pelvic examination should be performed very cautiously. If abnormal enlargement occurs Clomid 50 mg Tablets should not be given until the ovaries have returned to pre-treatment size. Ovarian enlargement and cyst formation associated with Clomid 50 mg Tablets therapy usually regress spontaneously within a few days or weeks after discontinuing treatment. Most of these patients should be managed conservatively. The dosage and/or duration of the next course of treatment should be reduced.<br /><u>Visual Symptoms:</u><br />Patients should be advised that blurring or other visual symptoms such as spots or flashes (scintillating scotomata) may occasionally occur during or shortly after therapy with Clomid 50 mg Tablets. These visual disturbances are usually reversible; however, cases of prolonged visual disturbance have been reported including after Clomid 50 mg Tablet discontinuation. The visual disturbances may be irreversible especially with increased dosage or duration of therapy. The significance of these visual symptoms is not understood. If the patient has any visual symptoms, treatment should be discontinued, and ophthalmologic evaluation performed.<br />Patients should be warned that visual symptoms may render such activities as driving a car or operating machinery more hazardous than usual, particularly under conditions of variable lighting.<br /><u>Precautions:</u><br />Cases of hypertriglyceridemia have been reported (see section 4.8) in the post-marketing experience with Clomid 50 mg Tablets. Pre-existing or family history of hyperlipidemia and use of higher than recommended dose and/or longer duration of treatment with Clomid 50 mg Tablets are associated with risk of hypertriglyceridemia. Periodic monitoring of plasma triglycerides may be indicated in these patients.<br /><u>Multiple Pregnancy:</u><br />There is an increased chance of multiple pregnancy when conception occurs in relationship to Clomid 50 mg Tablets therapy. The potential complications and hazards of multiple pregnancy should be discussed with the patient. During the clinical investigation studies, the incidence of multiple pregnancy was 7.9% (186 of 2369 Clomid 50 mg Tablets associated pregnancies on which outcome was reported). Among these 2369 pregnancies, 165 (6.9%) twin, 11 (0.5%) triplet, 7 (0.3%) quadruplet and 3 (0.13%) quintuplet. Of the 165 twin pregnancies for which sufficient information was available, the ratio of monozygotic twins was 1:5.<br /><u>Ectopic Pregnancy:</u></p><p>There is an increased chance of ectopic pregnancy (including tubal and ovarian sites) in women who conceive following Clomid 50 mg Tablets therapy. Multiple pregnancies, including simultaneous intrauterine and extrauterine pregnancies, have been reported.<br /><u>Uterine Fibroids:</u><br />Caution should be exercised when using Clomid 50 mg Tablets in patients with uterine fibroids due to potential for further enlargement of the fibroids.<br /><u>Pregnancy Wastage and Birth Anomalies:</u><br />The overall incidence of reported birth anomalies from pregnancies associated with maternal Clomid 50 mg Tablets ingestion (before or after conception) during the investigational studies was within the range of that reported in the published references for the general population. Among the birth anomalies spontaneously reported in the published literature as individual cases, the proportion of neural tube defects has been high among pregnancies associated with ovulation induced by Clomid 50 mg Tablets, but this has not been supported by data from population-based studies.<br />The physician should explain so that the patient understands the assumed risk of any pregnancy whether the ovulation was induced with the aid of Clomid 50 mg Tablets or occurred naturally.<br />The patient should be informed of the greater pregnancy risks associated with certain characteristics or conditions of any pregnant woman: e.g. age of female and male partner, history of spontaneous abortions, Rh genotype, abnormal menstrual history, infertility history (regardless of cause), organic heart disease, diabetes, exposure to infectious agents such as rubella, familial history of birth anomaly, and other risk factors that may be pertinent to the patient for whom Clomid 50 mg Tablets is being considered. Based upon the evaluation of the patient, genetic counselling may be indicated.<br />Population based reports have been published on possible elevation of risk of Down&rsquo;s Syndrome in ovulation induction cases and of increase in trisomy defects among spontaneously aborted fetuses from sub-fertile women receiving ovulation inducing drugs (no women with Clomid 50 mg Tablets alone and without additional inducing drug). However, as yet, the reported observations are too few to confirm or not confirm the presence of an increased risk that would justify amniocentesis other than for the usual indications because of age and family history.<br />The experience from patients of all diagnosis during clinical investigation of Clomid 50 mg Tablets shows a pregnancy (single and multiple) wastage or fetal loss rate of 21.4% (abortion rate of 19.0%), ectopic pregnancies, 1.18%, hydatidiform mole, 0.17%, fetus papyraceous, 0.04% and of pregnancies with one or more stillbirths, 1.01%.<br />Clomid 50 mg Tablets therapy after conception was reported for 158 of the 2369 delivered and reported pregnancies in the clinical investigations. Of these 158 pregnancies 8 infants (born of 7 pregnancies) were reported to have birth defects.<br />There was no difference in reported incidence of birth defects whether Clomid 50 mg Tablets was given before the 19th day after conception or between the 20th and 35th day after conception. This incidence is within the anticipated range of general population.<br /><u>Ovarian Cancer:</u><br />There have been rare reports of ovarian cancer with fertility drugs; infertility itself is a primary risk factor.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clomid 50 mg Tablets is not indicated during pregnancy. Although there is no evidence that Clomid 50 mg Tablets has a harmful effect on the human fetus, there is evidence that Clomid 50 mg Tablets has a deleterious effect on rat and rabbit fetuses when given in high doses to the pregnant animal. To avoid inadvertent Clomid 50 mg Tablets administration during early pregnancy, appropriate tests should be utilised during each treatment cycle to determine whether ovulation occurs. The patient should have a pregnancy test before the next course of Clomid 50 mg Tablets therapy.<br />It is not known whether Clomifene citrate is excreted in human milk. Clomifene may reduce lactation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients should be warned that visual symptoms may render such activities as driving a car or operating machinery more hazardous than usual, particularly under conditions of variable lighting (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Symptoms/Signs/Conditions:</u><br />Adverse effects appeared to be dose-related, occurring more frequently at the higher dose and with the longer courses of treatment used in investigational studies. At recommended dosage, adverse effects are not prominent and infrequently interfere with treatment.<br />During the investigational studies, the more commonly reported adverse effects included ovarian enlargement (13.6%), vasomotor flushes (10.4%), abdominal-pelvic discomfort (distention, bloating) (5.5%), nausea and vomiting (2.2%), breast discomfort (2.1%), visual symptoms (1.5%), headache (1.3%) and intermenstrual spotting or menorrhagia (1.3%).<br /><u>Ovarian enlargement:</u><br />At recommended dosage, abnormal ovarian enlargement is infrequent although the usual cyclic variation in ovarian size may be exaggerated. Similarly, cyclic ovarian pain (mittelschmerz) may be accentuated. With higher or prolonged dosage, more frequent ovarian enlargement and cyst formation may occur, and the luteal phase of the cycle may be prolonged.<br />Rare instances of massive ovarian enlargement are recorded. Such an instance has been described in a patient with polycystic ovary syndrome whose Clomid 50 mg Tablets therapy consisted of 100 mg daily for 14 days. Abnormal ovarian enlargement usually regresses spontaneously; most of the patients with this condition should be treated conservatively.<br /><u>Eye/Visual Symptoms:</u><br />Symptoms described usually as &ldquo;blurring&rdquo; or spots or flashes (scintillating scotomata) increase in incidence with increasing total dose.<strong> </strong></p><p>These symptoms appear to be due to intensification and prolongation of after-images. After-images as such have also been reported. Symptoms often first appear or are accentuated with exposure to bright-light environment. Ophthalmologically definable scotomata, phosphenes and reduced visual acuity have been reported.<br />There are rare reports of cataracts and optic neuritis.<br />These visual disturbances are usually reversible. However, cases of prolonged visual disturbance have been reported, including after Clomid 50 mg Tablets have been discontinued. The visual disturbances may be irreversible, especially with increased dosage or duration of therapy.<br /><u>Genitourinary:</u><br />There are reports of new cases of endometriosis and exacerbation of pre-existing endometriosis during Clomid 50 mg Tablets therapy.<br />Multiple pregnancies, including simultaneous intrauterine and extrauterine pregnancies, have been reported. There is an increased chance of ectopic pregnancy in women who conceive following Clomid 50 mg Tablets therapy.<br />Reduced endometrial thickness (frequency not known)<br /><u>Tumours/neoplasms:</u><br />Isolated reports have been received on the occurrence of endocrine-related or dependent neoplasms or their aggravation (see section 4.4).<br /><u>Central nervous system:</u><br />Convulsions have been reported; patients with a history of seizures may be predisposed, transient paraesthesia (frequency not known), dizziness (frequency not known). In investigational patients, CNS symptoms/signs, conditions of dizziness, light-headedness/vertigo (0.9%), nervous tension/insomnia (0.8%) and fatigue/depression (0.7%) were reported. After prescription availability, there were isolated additional reports of these conditions and also reports of other conditions such as syncope/fainting, cerebrovascular accident, cerebral thrombosis, psychotic reactions including paranoid psychosis, neurologic impairment, disorientation and speech disturbance.<br /><u>Psychiatric disorders:</u><br />Anxiety (frequency not known), depression (frequency not known), mood disturbances (including mood altered, mood swings and irritability) (frequency not known), nervousness (frequency not known), insomnia (frequency not known).<br /><u>Dermatoses:</u><br />Dermatitis and rash were reported by investigational patients. Conditions such as rash and urticaria were the most common ones reported after prescription availability but also reported were conditions such as allergic reaction, erythema multiforme, ecchymosis and angioneurotic oedema. Hair thinning (alopecia) has been reported very rarely.<br /><u>Liver function:</u><br />Bromsulphalein (BSP) retention of greater than 5% was reported in 32 of 141 patients in whom it was measured, including 5 of 43 patients who took approximately the dose of Clomid 50 mg Tablets now recommended. Retention was usually minimal unless associated with prolonged continuous Clomid 50 mg Tablets administration or with apparently unrelated liver disease. Other liver function tests were usually normal. In a later study in which patients were given 6</p><p>consecutive monthly courses of Clomid 50 mg Tablets (50 mg or 100 mg daily for 3 days) or matching placebo, BSP tests were done on 94 patients. Values in excess of 5% retention were recorded in 11 patients, 6 of whom had taken drug and 5 placebos.<br />In a separate report, one patient taking 50 mg of Clomid 50 mg Tablets daily developed jaundice on the 19th day of treatment; liver biopsy revealed bile stasis without evidence of hepatitis.<br /><u>Metabolism disorders:</u><br />Hypertriglyceridemia (frequency not known), in some cases with pancreatitis, has been observed in patients with pre-existing or a family history of hypertriglyceridemia and/or with dose and duration of treatment exceeding the label recommendations.<br /><u>Cardiac disorders:</u><br />Tachycardia, (frequency not known) palpitations (frequency not known)<br /><u>Hepatobiliary disorders:</u><br />Increased Transaminases<br /><u>Gastrointestinal disorders:</u><br />Pancreatitis (frequency not known)<br /><strong>To report any side effect(s):<br />&bull; Saudi Arabia:</strong><br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />&bull; SFDA call center : 19999<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: https://ade.sfda.gov.sa/<br />&bull; Sanofi- Pharmacovigilance: KSA_Pharmacovigilance@sanofi.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Toxic effects of acute overdosage of Clomid 50 mg Tablets have not been reported but the number of overdose cases recorded is small. In the event of overdose, appropriate supportive measures should be employed.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: ovulation stimulants, synthetic<br />ATC code: G03BG02<br /><u>Mechanism of action:</u><br />The ovulatory response to cyclic Clomid 50 mg Tablets therapy is mediated through increased output of pituitary gonadotrophins, which in turn stimulates the maturation and endocrine activity of the ovarian follicle.</p><p><u>Pharmacodynamic effects:</u><br />Clomid 50 mg Tablets is a triarylethylene compound (related to chlorotrianisene and triparanol). It is a non-steroidal agent which stimulates ovulation in a high percentage of appropriately selected anovulatory women.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Orally administered 14C labelled Clomifene citrate was readily absorbed when administered to humans. Cumulative excretion of the 14C label by way of urine and feces averaged about 50% of the oral dose after 5 days in 6 subjects, with mean urinary excretion of 7.8% and mean fecal excretion of 42.4%.<br />A mean rate of excretion of 0.73% per day of the 14C dose after 31 &ndash; 35 days and 0.45% per day of the 14C dose after 42 &ndash; 45 days was seen in fecal and urine samples collected from 6 subjects for 14 &ndash; 53 days after Clomifene citrate 14C administration.<br />The remaining drug/metabolites may be slowly excreted from a sequestered enterohepatic recirculation pool.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Long-term carcinogenicity studies have not been performed to evaluate the carcinogenic potential of Clomid.<br />Clomifene citrate did not induce gene mutations in bacteria (Ames test) or chromosome aberrations in cultured human peripheral blood lymphocytes. Clomifene citrate at oral doses up to 2000 mg/kg/day did not induce genotoxic effects in rats. At the highest dose tested of 2000 mg/kg/day in rats, the ratios of exposure ranged from 2 &ndash; 232 for Z-clomifene and E-clomifene respectively, taking into account limited PK data available in humans.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sucrose<br />Lactose<br />Soluble starch<br />Maize starch<br />Magnesium stearate<br />Iron oxide yellow E172<br />Purified Water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in original container, do not store above 25C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blister pack:<br />Base: 250-micron PVC<br />Foil: 20 micron hard-tempered aluminium<br />(in cardboard cartons)<br />Pack sizes: 30 and 100 tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sanofi Aventis France
82, avenue Raspail, 94250, Gentilly
France

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                12/02/2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>